Back to JACOBS LEVY EQUITY MANAGEMENT, INC JACOBS LEVY EQUITY MANAGEMENT, INC

KROSKROS
5 quarters

Position history for JACOBS LEVY EQUITY MANAGEMENT, INCJACOBS LEVY EQUITY MANAGEMENT, INC's holdings in KEROS THERAPEUTICS INC

JACOBS LEVY EQUITY MANAGEMENT, INC holds 605,445 shares of KROS (KEROS THERAPEUTICS INC), worth $6.5M as of 2026-Q2. The position was decreased (-14.3% shares). KROS represents 0.0% of JACOBS LEVY EQUITY MANAGEMENT, INC's portfolio.

Current Value

$6.5M

Current Shares

605,445

Total Value Change

-$521,677

Total Shares Change

+81,105

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
605,445
-14.3%
$6.5M0.0%$10.70
0
2026-Q1
Decreased
706,071
-8.1%
$7.8M0.0%$13.40
0
2025-Q4
Increased
768,425
+26.6%
$15.6M0.1%$20.27
35
2025-Q3
Increased
607,089
+15.8%
$9.6M0.0%$15.95
32
2025-Q2
New
524,340
-
$7M0.0%$13.49
38

Other major holders of KROS: BlackRock Finance, Inc., RA CAPITAL MANAGEMENT, L.P., ALKEON CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used